FDA authorizes bivalent Covid boosters for children 6 months and up
Kids 6 months and older are now eligible to receive Omicron-specific boosters for Covid-19, as US vaccination rates among children remain low.
The FDA on Thursday extended the emergency use authorizations for both Moderna and Pfizer’s updated bivalent vaccines, which include mRNA components of the original coronavirus strain and the BA.4 and BA.5 lineages.
The Omicron BQ.1 and BQ.1.1 strains are currently dominant in the US, accounting for more than 60% of all cases, according to the CDC’s tracker.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.